US Biologic, Global Lyme Alliance, and Center for Lyme Action Celebrate Passage of Delaware Bill to Fight Ticks at the Animal Source
WASHINGTON, Oct. 31, 2024 /PRNewswire/ — US Biologic, Inc., Global Lyme Alliance (GLA), and the Center for Lyme Action (CLA) celebrate today the passage of Delaware HB404 bill, “AN ACT TO AMEND TITLE 3 OF THE DELAWARE CODE RELATING TO LYME DISEASE” (bill detail), which creates a Ly
DermRays Set to Launch New Men’s Hair Removal Device Summer 2025
PLEASANTON, Calif., Oct. 31, 2024 /PRNewswire/ — DermRays is excited to announce a groundbreaking addition to its product line aimed specifically at male users. Set to launch in the summer of 2025, the new men’s hair removal device will feature an entirely new design and upgraded functio
ESSA Pharma Announces Termination of Phase 2 Study Evaluating Masofaniten Combined with Enzalutamide in Patients with Metastatic Castration-Resistant Prostate Cancer
Efficacy signals observed will not achieve ESSA’s target product profile in patients with metastatic castration-resistant prostate cancer naïve to second-generation antiandrogens A futility analysis conducted as part of a protocol-specified interim review of the safety, PK and efficacy data
Shining a Light on Familial Hypercholesterolemia: ABC Promotes Awareness During National Sudden Cardiac Arrest Awareness Month
ABC’s ‘Family Heartbeats Unmasked’ inspires awareness and action through the heartfelt stories of families diagnosed with FH. WASHINGTON, Oct. 31, 2024 /PRNewswire/ — As part of its ongoing commitment to raise awareness about heart health and address health disparities, the A
Media Advisory – Deputy Prime Minister’s itinerary for Friday, November 1, 2024
OTTAWA, ON, Oct. 31, 2024 /CNW/ – Note: All times local. Sault Ste. Marie, Ontario Private meetings. The Deputy Prime Minister will meet with leaders in the steel industry. Closed to media. 10:30 a.m. The Deputy Prime Minister will tour a veteran housing development and deliver remarks. Notes
CCR – Results for the 3rd quarter of 2024
SÃO PAULO, Nov. 1, 2024 /PRNewswire/ — Highlights The Company announced the extension of Renovias’ term until April 13, 2026. Further details can be found in the regulatory matters section. Record traffic in all platforms, with growths of 4.4% in toll roads, 5.1% in urban mobility, and
LianLian Global Partners with Cyberport to Offer a Rapid, Secure, and Cost-Effective Global Payment Experience
HANGZHOU, China, Nov. 1, 2024 /PRNewswire/ — The 2024 edition of Hong Kong FinTech Week, a premier financial technology event in Asia, was held on October 28 at the AsiaWorld-Expo in Hong Kong. LianLian Global, a subsidiary of Hong Kong-listed Lianlian DigiTech, participated in the event as a
Ignacio del Pino appointed Chief Investment Officer of Ferrovial
After 13 years of successful contribution to the company, Maria Teresa Pulido will retire from her role as Chief Strategy Officer on Dec 31 AMSTERDAM, Oct. 31, 2024 /PRNewswire/ — The Board of Directors of Ferrovial, a leading global infrastructure company, has approved the appointment of Ign
Levine Leichtman Capital Partners Named to Inc.’s 2024 List of Founder-Friendly Investors
LOS ANGELES, Oct. 31, 2024 /PRNewswire/ — Levine Leichtman Capital Partners (“LLCP”) is proud to announce that it has been named to Inc.’s 2024 Founder-Friendly Investors list for the second consecutive year. This prestigious list recognizes private equity, venture capital, a
Pangea Laboratory Partners with Unilabs to Introduce Bladder CARE™ Assay in Switzerland, Advancing Non-Invasive Cancer Diagnostics Across Europe
TUSTIN, Calif., Nov. 1, 2024 /PRNewswire/ — Pangea Laboratory has partnered with Unilabs, a leading European provider of clinical laboratory testing and diagnostic imaging services, to bring the Bladder CARE™ Assay to Switzerland. Under this agreement, the Bladder CARE™ Assay will be cover
